Benzodiazepines are the primary medications used to treat alcohol withdrawal. They remain the gold standard because they act on the same brain receptors that alcohol affects, calming the nervous system and preventing seizures. The specific drug and dose depend on how severe the withdrawal is, whether the person has liver problems, and what setting they’re being treated in.
How Withdrawal Severity Guides Treatment
Doctors assess withdrawal using a standardized scoring system called the CIWA-Ar, which rates symptoms like tremor, sweating, anxiety, and agitation on a point scale. Medication is typically started when the score reaches 8 or higher. If someone is already on a scheduled medication regimen and their score climbs to 15 or higher, additional doses are given on top of the regular schedule.
This scoring matters because mild withdrawal (shaky hands, mild anxiety, sweating) may not need the same aggressive treatment as severe withdrawal, which can involve hallucinations, dangerously high heart rate, or seizures. The medication choice branches based on this severity.
Benzodiazepines for Moderate to Severe Withdrawal
Three benzodiazepines are used most often: diazepam (Valium), lorazepam (Ativan), and chlordiazepoxide (Librium). They all work by enhancing the same calming brain signal that alcohol artificially boosted, which is why the brain becomes dangerously overexcited when alcohol is suddenly removed.
Diazepam is a common first choice. It acts quickly and has a long half-life of roughly 44 to 48 hours, meaning it tapers itself naturally in the body. For moderate withdrawal on a fixed schedule, a typical approach starts at a higher dose taken four times daily, then steps down over about five days. In a symptom-triggered approach, doses of 10 to 20 mg are given only when symptoms flare, which tends to result in less total medication and shorter treatment.
Lorazepam is preferred when liver function is a concern, which is common in heavy drinkers. Unlike diazepam and chlordiazepoxide, which are broken down through liver pathways that chronic alcohol use can impair, lorazepam is processed through a simpler metabolic route called glucuronidation that remains functional even in liver disease. Its half-life is shorter (about 12 hours), so it doesn’t linger as long and needs more frequent dosing, but it’s safer for people with cirrhosis or alcoholic hepatitis. Oxazepam shares this same metabolic advantage.
Symptom-Triggered vs. Fixed-Schedule Dosing
There are two main approaches to giving benzodiazepines. In symptom-triggered dosing, a trained clinician checks symptoms regularly and gives medication only when the score crosses the threshold. This approach requires skilled staff who can monitor frequently and respond to complications. In a fixed-schedule taper, the medication is given at set times and doses that decrease over several days regardless of symptoms. Fixed schedules are used when close monitoring isn’t available, though patients with a history of seizures or delirium tremens during past withdrawals generally need a higher level of care than a fixed taper can provide.
Anticonvulsants for Mild Withdrawal
For people with mild symptoms, two anticonvulsant medications can serve as alternatives to benzodiazepines: gabapentin (Neurontin) and carbamazepine (Tegretol). Both can reduce the anxiety, tremor, and irritability of mild withdrawal, and they carry no risk of the dependence that benzodiazepines do.
Gabapentin is typically started with a loading dose of 1,200 mg, then given at 600 to 1,200 mg per day for the first three days before tapering down to 300 to 600 mg per day through day seven. Carbamazepine follows a similar tapering pattern, starting at 600 to 800 mg per day and decreasing to 200 to 400 mg per day over four to nine days.
One important limitation: neither gabapentin nor carbamazepine reliably prevents withdrawal seizures or delirium tremens. They work best for people whose withdrawal history is uncomplicated and whose current symptoms are mild. They can also be added alongside benzodiazepines when symptoms persist despite adequate benzodiazepine doses.
Phenobarbital for Severe or Resistant Cases
When someone doesn’t respond to high doses of benzodiazepines, the withdrawal is classified as benzodiazepine-resistant. True delirium tremens, the most dangerous form of withdrawal, often falls into this category. Phenobarbital, a long-acting barbiturate, is the main rescue medication in these situations.
Phenobarbital works on the same calming brain pathway as benzodiazepines but through a slightly different mechanism, making it effective even when benzodiazepines aren’t enough. For someone who has had a withdrawal seizure, clinicians escalate rapidly toward a weight-based dose. The total amount must be carefully tracked because phenobarbital and benzodiazepines amplify each other’s sedating effects, and toxicity can occur at lower phenobarbital levels when benzodiazepines are also on board.
Adjunct Medications for Specific Symptoms
Benzodiazepines handle the core of withdrawal, but several other medications target specific symptoms that benzodiazepines don’t fully control.
- Clonidine: Reduces the autonomic overdrive of withdrawal, specifically the sweating, racing heart rate, and elevated blood pressure that come from the nervous system being in overdrive.
- Beta-blockers: Atenolol used alongside a benzodiazepine has been shown to normalize vital signs more quickly and reduce alcohol cravings more effectively than a benzodiazepine alone.
- Antipsychotics: Sometimes used for agitation or hallucinations, though they don’t prevent seizures and aren’t used as primary treatment.
Severe alcoholism also causes major nutritional deficits. Magnesium depletion is common and can require multiple intravenous doses to correct. People with heavy alcohol use are also at risk for refeeding syndrome when they start eating again, which may require phosphate replacement. Thiamine (vitamin B1) is given routinely to prevent a serious brain condition caused by deficiency.
Medications After Withdrawal Ends
Once someone is through acute withdrawal, a different set of medications can help prevent relapse. Three are FDA-approved for alcohol use disorder, and they work in completely different ways.
Naltrexone blocks the opioid receptors in the brain that make alcohol feel pleasurable. Normally, drinking triggers the release of the body’s natural feel-good chemicals and a surge of dopamine. Naltrexone intercepts that reward signal, reducing both the euphoria from drinking and the craving for it. It works best in people who have already stopped drinking before starting the medication. It’s available as a daily pill or a monthly injection.
Acamprosate helps stabilize brain chemistry that has been disrupted by long-term heavy drinking. It interacts with the glutamate system, one of the brain’s main excitatory pathways, and appears most effective at helping people who are already abstinent stay that way. It’s taken three times daily.
Disulfiram takes a completely different approach. It doesn’t reduce cravings at all. Instead, it blocks the body’s ability to process alcohol, so drinking even a small amount causes nausea, flushing, and a pounding headache. The idea is deterrence: knowing how miserable a drink will make you can help resist the urge. Evidence for its effectiveness is inconsistent, partly because it only works if the person actually takes it.
Liver Disease Changes the Playbook
Because chronic heavy drinking frequently damages the liver, medication choice often needs to account for impaired liver function. Diazepam and chlordiazepoxide rely on liver enzymes (CYP3A4 and CYP2C19) to be broken down. When those enzymes aren’t working well, the drugs accumulate and can cause excessive sedation. Lorazepam and oxazepam bypass those enzymes entirely, making them the safer options for anyone with known or suspected liver disease. That said, if liver function testing shows no impairment, there’s no medical reason to avoid the other benzodiazepines.